Major differences in specificity among naturally occurring human IgG-subclass anti-IgE autoantibodies - 12/09/11
Abstract |
Background: The specificity of naturally occurring IgG-subclass anti-IgE autoantibodies (a-IgE Ab) was studied by ELISA inhibition assay with a highly purified IgE-DES myeloma protein as a solid-phase antigen. Because the IgG isotypes differ in effector functions, detailed specificity studies of IgG subclass anti-IgE antibodies might clarify their putative role. Methods: Selected sera containing a high concentration of a single IgG a-IgE Ab subclass were allowed to react with purified immunoglobulins of all five classes including five different IgE myeloma proteins and papain-derived Fabϵ and Fcϵ fragments of IgE-DES. Results: The inhibition results indicated that IgG1, IgG2, and IgG3 a-IgE Ab reacted in a low-affinity reaction with IgE myeloma protein–restricted determinants because only IgE-DES was inhibitory. Moreover, the reacting epitopes were heat resistant (2 hours, 56° C) and localized in the Fabϵ-DES fragment. In sharp contrast, IgG4 a-IgE Ab reacted with high affinity to all five IgE myeloma proteins involving heat-susceptible epitopes confined to the Fcϵ fragment. Conclusions: It seems that a majority of IgG a-IgE Ab have a specificity for nonisotypic myeloma-restricted determinants whereas IgG4 a-IgE Ab were mainly isotype specific. These findings ought to be taken into account in the consideration of physiologic implications of IgG a-IgE Ab and in the interpretation of previous investigations in which intact IgE myeloma proteins have been used to detect IgG a-IgE Ab. (J ALLERGY CLIN IMMUNOL 1995;95:1011-9.)
Le texte complet de cet article est disponible en PDF.Keywords : Anti-IgE, assay, atopic, autoantibody, IgE, IgG4, IgG subclass, specificity
Abbreviations : a-IgE Ab, BSA, Mab, NIP, OD405 nm, PBS
Plan
| From the Department of Clinical Immunology, Karolinska Institute. |
|
| Supported by the Swedish Medical Research Council; the National Association for Prevention of Asthma and Allergies; Herman Krefting; Konsul Th. C. Berghs; Tore Nilson; and Karolinska Institute funds. |
|
| Reprint requests: Carl G.M. Magnusson, Dr.Med.Sci., Department of Clinical Immunology, Karolinska Hospital, S-171 76 Stockholm, Sweden. |
|
| 0091-6749/95 $3.00 + 0 1/1/62174 |
Vol 95 - N° 5
P. 1011-1019 - mai 1995 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
